German device industry sanguine over DAMA (Deutsche Arzneimittel- und Medizinproduktagentur)
This article was originally published in Clinica
The change in the German regulatory authority for devices from the federal BfArM institute to an agency, the DAMA (Deutsche Arzneimittel- und Medizinproduktagentur) in January 2006, will entail the establishment of a new medical technology regulatory department, called the Bundesstelle fur Medizinprodukte. It is foreseen that BfArM's current head of devices, Hans-Georg Will, will assume the devices head role in the agency.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.